Barclays Maintains an 'Overweight' on Amdocs Ltd. (DOX); Building Off of a Stable Foundation

February 24, 2011 2:06 PM EST Send to a Friend
Barclays maintains an 'Overweight' on Amdocs Ltd. (NYSE: DOX), PT $36.

Barclays analyst says, "Following Amdocs' analyst day, we believe ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login